Table of Contents

company-logo

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.

Vaxxinity Dividend Announcement

• Vaxxinity does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Vaxxinity dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Vaxxinity Dividend History

Vaxxinity Dividend Yield

Vaxxinity current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Vaxxinity stock? Use our calculator to estimate your expected dividend yield:

Vaxxinity Financial Ratios

P/E ratio-0.00
PEG ratio0.00
P/B ratio0.00
ROE-160.19%
Payout ratio0.00%
Current ratio1.89
Quick ratio1.89
Cash Ratio0.29

Vaxxinity Dividend FAQ

Does Vaxxinity stock pay dividends?
Vaxxinity does not currently pay dividends to its shareholders.
Has Vaxxinity ever paid a dividend?
No, Vaxxinity has no a history of paying dividends to its shareholders. Vaxxinity is not known for its dividend payments.
Why doesn't Vaxxinity pay dividends?
There are several potential reasons why Vaxxinity would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Vaxxinity ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Vaxxinity has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Vaxxinity a dividend aristocrat?
Vaxxinity is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Vaxxinity a dividend king?
Vaxxinity is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Vaxxinity a dividend stock?
No, Vaxxinity is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Vaxxinity stocks?
To buy Vaxxinity you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Vaxxinity stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.